Results 31 to 40 of about 361,579 (250)
Symptoms and Quality of Life in Gastroenteropancreatic Neuroendocrine Tumours [PDF]
European Medical Journal Oncology, 2014 Gastroenteropancreatic neuroendocrine tumours (GEP-NETs) have the ability to induce symptoms either by their direct mass effect on local tissues (symptoms such as pain, bowel obstruction, obstructive jaundice, and bleeding), or by the ectopic secretion ...
Rajaventhan Srirajaskanthan +1 more
doaj
Characterization of the neuroendocrine pancreatic tumors nature by MDCT enhancement pattern: a radio-pathological correlation [PDF]
, 2012 Introduction Pre-operative suspicion of neuroendocrine pancreatic lesions nature arises both from clinical (presence and the type of secreted hormone) and imaging findings.
NOVARIA, LISA
core +1 more source
Small intestinal neuroendocrine tumours - Disease models, tumour development, and remedy [PDF]
, 2019 Small intestinal neuroendocrine tumours (SINETs) are malignant neoplasms which at the time of diagnosis often present with distant metastasis. The field of SINET research faces several challenges. There is a lack of preclinical models for studying SINETs,
Hofving, Tobias
core +1 more source
Endocrine OncologyObjective: To evaluate clinical outcomes, safety and survival measures of octreotide infusion pump (OIP) therapy in patients with metastatic neuroendocrine tumors (NETs) and refractory hormonal syndrome.
Kalyan Mansukhbhai Shekhda +8 more
doaj +1 more source
The concurrent occurrence of neuroendocrine tumour and gastrointestinal stromal tumours [PDF]
Journal of Krishna Institute of Medical Sciences University, 2022 Gastrointestinal neuroendocrine tumours are hypothesised to arise from cells in the gastrointestinal tract's diffuse neuroendocrine system. The occurrence of Gastrointestinal Stromal Tumours (GIST) along with other primary gastrointestinal malignancies ...
Divya Rathod +3 more
doaj
Diagnostic characteristics, treatment outcomes, and prognostic factors in glucagonomas
Endocrine OncologyObjective: Glucagonomas are rare islet cell tumours, accounting for 2% of such tumours, with an annual incidence of 0.01–0.1 per million. This study aimed to describe diagnostic characteristics and treatment outcomes in patients with glucagonoma from a ...
Eleni Armeni +11 more
doaj +1 more source
Endocrine Connections, 2021 Calcitonin-secreting neuroendocrine neoplasms of the lung are rare, with few cases reported in the literature. Differentiating between medullary th yroid carcinoma and an ectopic source of calcitonin secretion can represent a complex diagnostic conundrum
David C Llewellyn +8 more
doaj +1 more source
Pediatric Blood &Cancer, EarlyView.ABSTRACT Pediatric gastroenteropancreatic neuroendocrine neoplasms (GEP‐NENs) are extremely rare and clinically heterogeneous. Management has largely been extrapolated from adult practice. This European Standard Clinical Practice Guideline (ESCP), developed by the EXPeRT network in collaboration with adult NEN experts, provides (adult) evidence ...
Michaela Kuhlen +23 more
wiley +1 more source
Neuroendocrine Tumour Markers [PDF]
, 1999 The neuroendocrine cells of the gastroenteropancreatic (GEP) axis belong to the APUD-system, because they are capable of amine precursor uptake and decarboxylation, leading to the production of amines and small peptides.
Nobels, FRE, Nobels, F.R.E. (Frank)
core +1 more source
Requiem for the Term ‘Carcinoid Tumour’ in the Gastrointestinal Tract?
Canadian Journal of Gastroenterology, 2008 Use of the term ‘carcinoid tumour’ to describe a unique type of tumour in the gastroenteropancreatic system is endemic in the medical literature and in daily clinical and pathological parlance.
Runjan Chetty
doaj +1 more source